This is a multicenter, observational registry that follows patients for a total of 5
years from the date of the first liver ablation procedure with the NEUWAVE Microwave
Ablation System.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04107766.
Locations matching your search criteria
United States
Wisconsin
Madison
University of Wisconsin Carbone Cancer Center - Eastpark Medical CenterStatus: Active
Contact: Timothy J Ziemlewicz
University of Wisconsin Carbone Cancer Center - University HospitalStatus: Active
Name Not Available
This is a multicenter, observational registry that follows patients for a total of 5
years from the date of the first liver ablation procedure with the NEUWAVE Microwave
Ablation System. The data gathered from participating sites will be available to be
analyzed to develop ablation parameter guidance for ablation approaches under varying
patient liver tissue conditions and liver lesions.
This is an "umbrella registry," which was included as an optional component in other
NEUWAVE studies; hence, data from consenting patients who are or will be enrolled in
other NEUWAVE soft tissue liver lesion ablation studies will be included in this
registry. All other patients will be enrolled and followed prospectively, enrolled
retrospectively with prospective, longitudinal follow up, or enrolled retrospectively
with all retrospective follow up.
Enrollment for this study will include up to 1,500 patients throughout the world who
underwent or are scheduled to undergo microwave ablation of one or more soft tissue liver
lesions using the NEUWAVE Microwave Ablation System or the NEUWAVE Microwave Ablation
System with Ablation Confirmation.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationEthicon Inc